Mostrando 2 resultados de: 2
Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
ArticleAbstract: Augmentation of immunogenicity can be achieved by particulate delivery of an antigen and by its co-aPalabras claves:adjuvant, CpG, R848, Resiquimod, Synthetic nanoparticle vaccine, TLR agonistAutores:Altreuter D.H., Basto P.A., Browning E.A., Farokhzad O.C., Frank Alexis, Iannacone M., Ilyinskii P.O., Johnston L.P.M., Kishimoto T.K., Langer R.S., O'Neil C.P., Pittet L.A., Radovic-Moreno A.F., Roy C.J., Shi J., Tonti E., von Andrian U.H.Fuentes:scopusTransepithelial transport of Fc-targeted nanoparticles by the neonatal Fc receptor for oral delivery
ArticleAbstract: Nanoparticles are poised to have a tremendous impact on the treatment of many diseases, but their brPalabras claves:Autores:Blumberg R., Farokhzad O.C., Frank Alexis, Karnik R., Kuo T., Langer R.S., Levy-Nissenbaum E., Pridgen E.M.Fuentes:scopus